Skip to content
Governance Register

← US public companies

Gall Matthew

SEC-identified person · CIK 1816194 Identifier-verified

Public-company roles (from insider filings)

CompanyCapacity as filedFilings
Tango Therapeutics, Inc. TNGX Chief Financial Officer filed 2026–2026
Kalaris Therapeutics, Inc. KLRS Chief Financial Officer filed 2025–2026
Iteos Therapeutics, Inc. ITOS Chief Financial Officer filed 2020–2025

All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.